A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2798745 in Participants With Diabetic Macular Edema
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to GlaxoSmithKline
Related studies linked through entity extraction aliases.
Efficacy and Safety Study of Mepolizumab 100 Milligram (mg) Subcutaneous (SC) in Indian Participants Aged Greater Than or Equal to (>=) 18 Years With Severe Eosinophilic Asthma
- Status
- COMPLETED
- Phase
- PHASE4
Study on TSR-042 in Advanced Clear Cell Sarcoma
- Status
- TERMINATED
- Phase
- PHASE2
ATR Inhibitor Elimusertib (BAY1895344) Plus Niraparib Phase 1b Study in Advanced Solid Tumors and Ovarian Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Microbiome and Exacerbations in Neutrophilic Asthma
- Status
- UNKNOWN
- Phase
- N/A
Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethasone Versus Daratumumab, Bortezomib and Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Niraparib Plus Aromatase Inhibitors for Luminal-like(HER2-,ER+) and gBRCA or HDR+ Metastatic Breast Cancer (LUZERN)
- Status
- COMPLETED
- Phase
- PHASE2
Compliance With Clinical Guidelines and Effect on Patient Outcome of Treatment of Hospitalised Exacerbations of COPD
- Status
- UNKNOWN
- Phase
- N/A
A Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Protein BG505 SOSIP.GT1.1 Gp140 Vaccine, Adjuvanted in Healthy, HIV-uninfected Adults
- Status
- COMPLETED
- Phase
- PHASE1
Comparative Study to Evaluate Efficacy and Safety of Gepotidacin to Nitrofurantoin in Treatment of Uncomplicated Urinary Tract Infection (UTI)
- Status
- COMPLETED
- Phase
- PHASE3
Enhanced Population-based Core Surveillance of Meningococcal Invasive Infections at Participating Centers Across Canada
- Status
- UNKNOWN
- Phase
- N/A
Study of Subcutaneous (SC) Belimumab in Pediatric Participants With Systemic Lupus Erythematosus (SLE)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Belantamab Mafodotin to Investigate Safety, Tolerability, Pharmacokinetics, Immunogenicity and Clinical Activity in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Test GlaxoSmithKline's (GSK) Herpes Zoster (HZ) Subunit Vaccine's Long-term Immune Response in Previously Vaccinated Kidney Transplant Adults and Then to Test if 2 Additional Doses of the Vaccine Are Safe and Able to Generate an Immune Response
- Status
- COMPLETED
- Phase
- PHASE3
Linerixibat Long-term Safety, and Tolerability Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study of Single Agent Belantamab Mafodotin Versus Pomalidomide Plus Low-dose Dexamethasone (Pom/Dex) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study to Evaluate Safety, Tolerability and Efficacy of GSK2330811 in Crohn's Disease
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Diphtheria, Pertussis and Tetanus (Tdap) Viruses Followed by a 2nd Dose of the RSV Vaccine to Healthy Non-Pregnant Women
- Status
- COMPLETED
- Phase
- PHASE2
Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of GSK2330811 in Healthy Japanese Participants
- Status
- COMPLETED
- Phase
- PHASE1
Single Dose Study to Investigate the Pharmacokinetics (PK) and Safety of Belimumab 200 Milligrams (mg) Intravenous and 200 mg Subcutaneous Via Auto-injector in Chinese Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1